Over the years, many hands have been wrung over clinical trial recruitment – low participation ... But in a world of patient engagement and ubiquitous technology, part of the answer seems ...

But with cancer remaining as one of the most prevalent and deadly forms of disease worldwide, there are a staggering number ...

With chemotherapy currently the main form of treatment, HG-CT-1 is based on a potentially more benign and effective CAR-T therapy, which uses and modifies a patient's own immune cells to recognize and ...

Dimerix (ASX:DXB) secured orphan drug designation for the treatment in the US and Europe, opening the door to a faster ...

Imugene has dosed the first Australian subject in a Phase Ib trial of its allogeneic CAR T-cell therapy, azer-cel (azercabtagene zapreleucel).

Jay Ferro is the Chief Information, Technology and Product Officer at Clario, he has over 25 years of experience leading ...

Hemogenyx Pharmaceuticals Opens First Clinical Site for HG-CT-1 Phase I TrialPatient Recruitment Begins for CAR-T Cell Therapy Targeting Relapsed/Refractory Acute Myeloid Leukemia in Adults LONDON, UK ...

INR:6263. 23 tarikh ka lottery TaiGen Biopharma's new anti-influenza drug is approved for clinical trials in the U.S., without the restriction of taking the ...

Ensuring patients understand the commitment and providing resources are crucial for maintaining quality of life during trials. Open dialogue and mitigation strategies for side effects are emphasized ...

Follicular lymphoma is considered an indolent disease, with long-term tumour control achieved by first-line ...